Anti-AMHR2 Aptamer SELEX Service(Cat#: CTApt-1158)

This is an aptamer development services to screening aptamers binds to the AMHR2 with an affinity of 1nM~1μM.

Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target AMHR2
Alternative Names Anti-Mullerian Hormone Receptor Type 2; MISRII; MISR2; Muellerian Inhibiting Substance Type II Receptor; Anti-Muellerian Hormone Type II Receptor; Anti-Muellerian Hormone Type-2 Receptor; AMH Type II Receptor; MIS Type II Receptor; EC 2.7.11.30; AMHR; MRII; Mullerian Inhibiting Substance Type II Receptor; Anti-Mullerian Hormone Receptor, Type II; Anti-Mullerian Hormone Receptor Type II; AMHR2
Gene ID 269
UniProt ID Q16671
Target Overview This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry